ATI RN
ATI RN Pharmacology 2023 retake 1 Questions
Extract:
Question 1 of 5
A nurse is assessing a client who is taking warfarin. Which of the following findings should the nurse identify as the priority to report to the provider?
Correct Answer: B
Rationale: The correct answer is B: Melena. Melena is a sign of gastrointestinal bleeding, which can be a serious complication of warfarin therapy due to its anticoagulant effect. This finding requires immediate attention to prevent further bleeding.
Other choices:
A: Hair loss - Not a priority as it is a common side effect of warfarin but does not indicate an urgent issue.
C: Abdominal cramping - Common side effect of warfarin and not a priority unless severe or accompanied by other concerning symptoms.
D: Fever - Although fever may indicate infection, it is not directly related to warfarin therapy and does not require immediate reporting in this context.
Question 2 of 5
A nurse is teaching a client who has a new prescription for total parenteral nutrition (TPN). Which of the following information should the nurse include in the teaching?
Correct Answer: C
Rationale: The correct answer is C: The TPN will provide nutrients while your bowels have time to rest. TPN is a form of nutrition provided through an IV line directly into the bloodstream, bypassing the digestive system. This allows the bowels to rest and heal while still receiving essential nutrients. Option A is incorrect as TPN does not stimulate appetite. Option B is incorrect because TPN is not primarily for medication absorption. Option D is incorrect as TPN does not specifically keep bowels clear for surgery.
Question 3 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: D
Rationale: The correct answer is D: Furosemide and amikacin. Furosemide and amikacin can both cause hearing loss independently, and when used together, they increase the risk of ototoxicity. Furosemide is a loop diuretic known to cause hearing loss, especially at higher doses. Amikacin is an aminoglycoside antibiotic that is also associated with ototoxicity.
Therefore, monitoring for hearing loss is crucial when these medications are used together.
Choices A, B, and C do not involve medications known to cause hearing loss or interact to increase the risk.
Question 4 of 5
A nurse is caring for a client who has a gonococcal infection and has been prescribed an IM injection of ceftriaxone. The client refuses the medication because they are afraid of needles. Which of the following responses should the nurse make?
Correct Answer: D
Rationale: The correct response is D: I will discuss other treatment options with your provider. This is the best response because it acknowledges the client's fear of needles and shows empathy. The nurse is addressing the client's concerns and is offering to explore alternative treatment options that may be more acceptable to the client. This response promotes client autonomy and collaboration in decision-making, ensuring that the client receives appropriate care while respecting their preferences.
Choice A is incorrect as it minimizes the client's fear without addressing the underlying issue.
Choice B is incorrect as it uses coercion and does not consider the client's feelings.
Choice C is incorrect as it uses a scare tactic to pressure the client into compliance, which is not therapeutic.
Question 5 of 5
A nurse is preparing to administer a scheduled dose of warfarin to a client. Which of the following laboratory tests should the nurse review prior to administration?
Correct Answer: B
Rationale: The correct answer is B: PT. The prothrombin time (PT) measures the time it takes for blood to clot, which is crucial for monitoring warfarin therapy. Warfarin is an anticoagulant that works by inhibiting the clotting factors that rely on vitamin K, thus prolonging the PT. Reviewing the PT prior to administering warfarin ensures that the client's blood is clotting appropriately and helps prevent potential bleeding complications.
Incorrect Answers:
A: PTT - Partial thromboplastin time measures the intrinsic pathway of the clotting cascade and is not specific to warfarin therapy.
C: WBC - White blood cell count is unrelated to warfarin administration.
D:
Total iron-binding capacity - TIBC assesses the body's ability to bind and transport iron, not relevant to warfarin therapy.